17
Participants
Start Date
March 31, 2016
Primary Completion Date
June 1, 2018
Study Completion Date
June 1, 2018
Ledipasvir 90 mg/Sofosbuvir 400 mg
Oral administration on one fixed dose combination tablet for 12 weeks
Ribavirin
Oral administration of body weight-dose adjusted, 200 mg-tablets of ribavirin (1,000 mg in two administration in patients \<75 Kg of body weight, or 1,200 mg in two administrations for those \>75 Kg) for 12 weeks.
Division of Gastroenterology and hepatology, University Hospital, Geneva
Gastaldi Giacomo
UNKNOWN
Clément Sophie
UNKNOWN
University Hospital, Geneva
OTHER